文献速递老年与多病共存慢病管理

建立患者与家庭研究顾问团以纳入重病、多病共存及高龄人群

Developing a patient and family research advisory panel to include people with significant disease, multimorbidity and advanced age.
PubMed 文献 · Fam Pract · 2017-01-01

该文描述了在美国科罗拉多大学建立常设患者与家庭顾问团的过程,旨在将重病、多病共存和/或高龄人群的声音纳入研究。顾问团由八名有相关经验的顾问、两名医生和一名项目经理组成,每两个月开会2小时,主要为目标多样的研究者提供健康照护研究咨询。作者认为该人群在美国不断增长,其参与研究对医疗模式从数量向价值转变至关重要。

要点

  • 顾问团含八名有重病、多病共存和/或高龄经验的顾问、两名医生和一名项目经理。
  • 顾问团每两个月开会2小时,主要为目标多样的研究者提供健康照护研究咨询。
  • 该人群是医疗系统高利用者,但参与研究议程制定的正式机会很少。

核心结论

  • 重病、多病共存和/或高龄人群在美国是不断增长的人群,其参与研究对医疗模式从数量向价值转变至关重要。

研究设计与样本

  • 该文描述了在美国科罗拉多大学建立常设患者与家庭顾问团的过程,初步建设包括需求评估、信息收集和参与者招募。
  • 研究者收集了咨询顾问团的研究者以及顾问团成员的反馈,以更好地理解患者和家庭成员视角的体验。

主要发现

  • 患者与家庭研究顾问团由八名有重病、多病共存和/或高龄经验的顾问、两名医生和一名项目经理组成。
  • 顾问团每两个月开会2小时,主要目的是为目标多样的研究者提供健康照护研究咨询。

临床怎么用

  • 全科医学智能体医生可参考该模式,建立患者与家庭顾问团,将重病、多病共存和高龄人群的声音纳入研究议程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: People who have experienced illness due to significant disease, multimorbidity and/or advanced age are high utilizers of the health care system. Yet this population has had little formal opportunity to participate in guiding the health care research agenda, and few mechanisms exist for researchers to engage this population in an efficient way. OBJECTIVE: We describe the process of developing a standing patient and family advisory panel to incorporate this population's voice into research in the USA. METHODS: The panel was created at the University of Colorado. Preliminary panel development consisted of a needs assessment, information gathering and participant recruitment. We collected feedback from researchers who consulted with the panel and from panel members in order to better understand the experience from the patient and family member perspective. RESULTS: The patient and family research advisory panel consists of eight advisors who have experience with significant disease, multimorbidity and/or advanced age, two physicians and a program manager. The panel meets every other month for 2 hours with the main purpose of advising diverse researchers on health care studies. CONCLUSION: People with significant disease, multimorbidity and/or advanced age represent a growing demographic in the USA, and their engagement in research is essential as the model of health care delivery moves from volume to value.

来源:Fam Pract,查看原文。版权归原作者所有。

引用

  1. Portalupi LB, Lewis CL, Miller CD, et al. Developing a patient and family research advisory panel to include people with significant disease, multimorbidity and advanced age. Fam Pract. 2017. PMID: 28122848. doi:10.1093/fampra/cmw138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。